18 Results for "

PKA-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (18)

18 Results for "PKA-IN-1" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-115732
CAS No.: 179985-52-5
Purity:  99.82%
Target:  

PKA

Research Areas:  

Inflammation/Immunology

PKA-IN-1 is a potent and selective cyclic AMP-dependent protein kinase (PKA) catalytic subunit (cAK) inhibitor with an IC50 of 0.03 μM. PKA-IN-1 inhibits cAK in a fashion that is competitive with respect to ATP as substrate [1].
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N2118
CAS No.: 521-32-4
Bilobetin, an active component of Ginkgo biloba, can reduce blood lipids and improve the effects of insulin. Bilobetin ameliorated insulin resistance, increased the hepatic uptake and oxidation of lipids, reduced very-low-density lipoprotein triglyceride secretion and blood triglyceride levels, enhanced the expression and activity of enzymes involved in β-oxidation and attenuated the accumulation of triglycerides and their metabolites in tissues. Bilobetin also increased the phosphorylation, nuclear translocation and activity of PPARα accompanied by elevated cAMP level and PKA activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-136172
CAS No.: 301177-43-5
Purity:  98.74%
Target:  

Ras

ESI-08 is a potent and selective EPAC antagonist, which can completely inhibit both EPAC1 and EPAC2 (IC50 of 8.4 μM) activity. ESI-08 selectively blocks cAMP-induced EPAC activation, but does not inhibit cAMP-mediated PKA activation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-119016
CAS No.: 1072443-89-0
Purity:  98.47%
Synonyms: BML-258
Target:  

SphK CaMK

Research Areas:  

Cancer

SK1-I (BML-258), an analog of sphingosine, is an isozyme-specific competitive SPHK1 inhibitor with a Ki value of 10 μM [1]. SK1-I shows no activity at SPHK1 PKCα, PKCδ, PKA, AKT1, ERK1, EGFR, CDK2, IKKβ or CamK2β. SK1-I enhances autophagy and has antitumor activity .
loading...
    loading...
Cat. No.: HY-175232
CAS No.: 488801-10-1
GL64 is a selective agonist of ADGRD1 (EC50 = 3.98 μM). GL64 has low selectivity for ADGRD2, ADGRG5, ADGRG6, CELSR1, CELSR2, CELSR3, and ADGRG4 isoforms. GL64 activates ADGRD1 by mimicking the satchel sequence. GL64 regulates osteoclast maturation through the cAMP-PKA-NFATC1 pathway. GL64 effectively inhibits osteoclastogenesis and prevents bone loss both in vitro and in vivo. GL64 is useful in the study of osteoclast-related diseases [1].
loading...
    loading...
Cat. No.: HY-W001242
CAS No.: 903550-26-5
1-(Tetrahydropyran-2-yl)-1H-pyrazole-5-boronic acid pinacol ester is a pharmaceutical intermediate used in the synthesis of naphthyl FXIa/PKa inhibitors .
loading...
    loading...
Cat. No.: HY-107544
CAS No.: 1152197-23-3
Target:  

PKA

Research Areas:  

Metabolic Disease

8-pCPT-2'-O-Me-cAMP-AM is a cyclic AMP analogue, selectively activates Epac-Rap signaling pathway. 8-pCPT-2'-O-Me-cAMP-AM protects renal function by activating Epac from ischemia injury. 8-pCPT-2'-O-Me-cAMP-AM also stimulates insulin secretion by interaction with PKA pathway .
loading...
    loading...
Cat. No.: HY-P10336
CAS No.: 1383743-23-4
Target:  

Serpin

Research Areas:  

Neurological Disease Endocrinology

Serpinin is an agonist of the protease inhibitor Nexin-1 (PN-1). Serpinin upregulates the expression of PN-1 through the cAMP-PKA-Sp1 signaling pathway, promoting granule biogenesis in endocrine cells. Serpinin is used in research related to the regulation of secretory function [1]. Serpinin is a selective agonist for β-adrenergic receptors. Serpinin interacts with β1-adrenergic receptors to activate the AC-cAMP-PKA pathway, which regulates myocardial systolic and diastolic function. pGlu-serpinin upregulates Bcl2 mRNA transcription and exerts neuroprotective effects .
loading...
    loading...
Cat. No.: HY-123520
CAS No.: 864082-35-9
Research Areas:  

Cancer

GSK299115A is a G Protein-coupled Receptor Kinase (GRK) and PKA inhibitor .
loading...
    loading...
Cat. No.: HY-N0521R
CAS No.: 3371-27-5
(-)-Gallocatechin (Standard) is the analytical standard of (-)-Gallocatechin. This product is intended for research and analytical applications. (-)-Gallocatechin, an epimer of (-)-Epigallocatechin (EGC), is contained in various tea products. (-)-Gallocatechin has antioxidant activities. (-)-Gallocatechin is the main active component in green tea extract (HTP-GTE) responsible for its effect of improving age-related cognitive impairments involving protein kinase A (PKA) pathway .
loading...
    loading...
Cat. No.: HY-143898
CAS No.: 2762767-48-4
Target:  

Pim

Research Areas:  

Cancer

PIM1-IN-4 (Compound 8) is a potent inhibitor of PIM1. PIM1-IN-4 reveals strong inhibition of five other enzymes, i.e., SGK-1, PKA, CaMK-1, GSK3β, and MSK1. PIM1-IN-4 has the potential for the research of cancer diseases [1].
loading...
    loading...
Cat. No.: HY-148868
CAS No.: 1334107-58-2
Target:  

Akt PKA CDK

Research Areas:  

Others

Akt1&PKA-IN-1 is a potent dual Akt/PKA inhibitor with IC50 values of 0.03 , 0.11 μM, and 9.8 μM for PKAa, Akt, and CDK2, respectively. Akt1&PKA-IN-1 is selective for cyclin-dependent kinase 2 (CDK2) [1].
loading...
    loading...
Cat. No.: HY-179133
CAS No.: 3021527-82-9
Target:  

P2Y Receptor PKA Raf MEK ERK

Research Areas:  

Inflammation/Immunology

HDB-1 is a selective inhibitor of the P2Y14 receptor (P2Y14R) with an IC50 of 26 pM. HDB-1 shows no significant inhibition on P2Y1R, P2Y2R, P2Y4R, P2Y6R, and P2Y12R. HDB-1 blocks the activation of hepatic stellate cells (HSC) by inhibiting the PKA/Raf1/MEK/ERK signaling pathway mediated by P2Y14R, thereby alleviating the core pathological process of liver fibrosis. HDB-1 can be used for the study of liver fibrosis [1].
loading...
    loading...
Cat. No.: HY-P10098
CAS No.: 121932-31-8
Target:  

PKA

Research Areas:  

Cancer

PKA Substrate is a potent and selective substrate peptide of PKA that can be used to detect PKA activity .
loading...
    loading...
Cat. No.: HY-P3920
CAS No.: 309247-46-9
Target:  

PKA

Research Areas:  

Cancer

Cys-Kemptide is a cysteine-terminated substrate peptide that can used to measure protein kinase A (PKA) activity .
loading...
    loading...
Cat. No.: HY-134298
CAS No.: 72549-36-1
Synonyms: 8-(4-Chlorophenylthio)-N6-phenyl-cAMP
Target:  

PKA

Research Areas:  

Others

8-CPT-6-Phe-cAMP is an analogue of signal molecule cAMP and a potent protein kinase A (PKA) activator .
loading...
    loading...
Cat. No.: HY-P3745
CAS No.: 65189-70-0
Target:  

PKA

Research Areas:  

Others

H1-7 (histone H1 phosphorylation site), PKA Substrate, a synthetic polypeptide, can be used as PKA substrate .
loading...
    loading...
Cat. No.: HY-N2118R
CAS No.: 521-32-4
Bilobetin (Standard) is the analytical standard of Bilobetin. This product is intended for research and analytical applications. Bilobetin, an active component of Ginkgo biloba, can reduce blood lipids and improve the effects of insulin. Bilobetin ameliorated insulin resistance, increased the hepatic uptake and oxidation of lipids, reduced very-low-density lipoprotein triglyceride secretion and blood triglyceride levels, enhanced the expression and activity of enzymes involved in β-oxidation and attenuated the accumulation of triglycerides and their metabolites in tissues. Bilobetin also increased the phosphorylation, nuclear translocation and activity of PPARα accompanied by elevated cAMP level and PKA activity .
loading...
    loading...
  • 1